1. Clinical Overview
Fluticasone Propionate is a potent, synthetic, trifluorinated glucocorticoid with high topical anti-inflammatory activity. The 0.005% w/v (equivalent to 50 mcg/mL or 0.05 mg/mL) concentration is primarily formulated for topical dermatological use. It acts by binding to glucocorticoid receptors, inhibiting the release of pro-inflammatory mediators, and reducing vasodilation and edema. It is considered a medium-potency topical corticosteroid in the Indian classification system.
| Onset | Duration | Bioavailability |
|---|---|---|
| Clinical improvement in inflammation and pruritus is typically observed within 3 to 5 days of starting therapy. | The anti-inflammatory effect persists for several hours post-application, necessitating once or twice-daily dosing. The clinical effect duration is linked to application frequency. | Topical bioavailability is low, estimated at less than 1-2% through intact skin. Systemic absorption increases with application over large surface areas, prolonged use, use under occlusion, or on inflamed/ulcerated skin. |
2. Mechanism of Action
Fluticasone propionate is a potent anti-inflammatory and immunosuppressive agent. It diffuses across cell membranes and binds with high affinity to cytoplasmic glucocorticoid receptors. The activated receptor complex translocates to the nucleus, where it modulates gene transcription. It increases the synthesis of anti-inflammatory proteins (like lipocortin-1) and decreases the synthesis of pro-inflammatory mediators.
3. Indications & Uses
- Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
- Atopic Dermatitis (Eczema)
- Psoriasis (excluding widespread plaque psoriasis)
- Contact Dermatitis (Allergic or Irritant)
- Seborrheic Dermatitis
- Lichen Planus
- Discoid Lupus Erythematosus (cutaneous lesions)
4. Dosage & Administration
Adult Dosage: Apply a thin film to the affected area once or twice daily. Frequency should be guided by severity; twice daily is common initially, tapering to once daily or less frequent as condition improves.
Administration: 1. Wash and dry the affected area gently. 2. Apply a thin layer (a pea-sized amount for an area the size of 2-3 adult palms) and rub in gently until it disappears. 3. Do not cover with airtight dressings (occlusion) unless specifically directed by a physician, as this increases absorption and side effects. 4. Wash hands after application unless hands are the treated area. 5. Avoid contact with eyes, mouth, nose, and mucous membranes.
5. Side Effects
Common side effects may include:
- Local burning or stinging sensation (usually transient)
- Skin dryness
- Itching at the application site
- Skin irritation
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Strong CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole, Ritonavir, Clarithromycin) | May inhibit the metabolism of systemically absorbed fluticasone, increasing the risk of systemic corticosteroid side effects and adrenal suppression. | Major |
| Other Topical Corticosteroids | Additive risk of local and systemic side effects. | Major |
| Live Vaccines (e.g., BCG, MMR, Varicella) | Theoretical risk of diminished immune response and potential vaccine-related infection if significant systemic immunosuppression occurs. | Moderate |
7. Patient Counselling
- DO use exactly as prescribed by your doctor.
- DO apply a thin layer only to the affected area.
- DO wash your hands before and after application (unless hands are treated).
- DO report any lack of improvement or worsening after 1-2 weeks.
- DON'T use on the face, groin, or armpits unless specifically told to do so.
- DON'T cover the area with tight bandages or plastic wraps unless instructed.
- DON'T use for longer than the prescribed duration.
- DON'T share your medication with others.
8. Toxicology & Storage
Overdose: Topical overdose manifests as severe local side effects: pronounced skin atrophy, striae, telangiectasia, HPA axis suppression (symptoms: fatigue, weakness, nausea, hypotension, hypoglycemia), and Cushingoid features. Acute ingestion of topical preparation is unlikely to cause acute systemic toxicity due to low bioavailability but may cause GI upset.
Storage: Store at room temperature (15-25°C). Protect from light and excessive heat. Do not freeze. Keep the tube tightly closed. Keep out of reach and sight of children. Do not use after the expiry date printed on the packaging.